Approval · Notice of Compliance 2574 · 2001
ALDACTONE: Notice of Compliance 2574
Issued August 17, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2574
- Date
- August 17, 2001
- Company
- Pharmacia Canada Inc.Baie D'Urfe, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Aldosterone antagonist
Products in this notice
Medicinal ingredients
- SPIRONOLACTONE 25 MG per TAB
- SPIRONOLACTONE 100 MG per TAB